Skip to main content

Posts Tagged ‘research and development’

Collaboration In Pharma Is Surging

There is probably no headline that comes out of a pharmaceutical company more frequently than one relating to collaboration. Collaboration between pharmaceutical companies and academia, hospitals, start-ups, and large pharma has been happening for a long time. However, the focus on collaboration has intensified in recent years, and for the right reasons. In fact, you […]

Pharma Leans On Private Equity To Fund Clinical Trials

In a time in which research and development costs are at an all-time high, The Wall Street Journal just shared how pharmaceutical companies are starting to look for outside help to fund trials: everything from phase II all the way through the commercial phase. Partnering with private equity firms, such as NovaQuest and Avillion, is […]

How Bad Trade Policy Impacts Pharma

The United States is known for massive innovation across sectors, especially in the pharmaceutical arena. According to the Pharmaceutical Research and Manufacturers of America, in 2015 member companies of the advocacy organization invested more than $58 billion in research and development, making the pharmaceutical industry the largest investor in research and development of any sector. […]

[Guide] The State Of The Life Sciences Industry

Last year’s presidential election invoked a great deal of angst in the pharmaceutical industry, with the cost of drugs taking center stage for a good portion of some candidates’ campaigns. While the things candidates said they would do could very well be different from what they might actually do, their words and records were enough […]

The Trump Administration’s Impact On Pharma

There are plenty of articles out there about how the pharmaceutical industry may be affected by Donald Trump’s presidency. The problem is that nobody exactly knows how things are going to pan out over the next few years. When it comes to health insurance, the price of drugs, and the quality of providers across the entire health […]

FDA’s New Chief Is A Tremendous Blessing For Industry

  Dr. Robert Califf, a cardiologist who has spent most of his career at Duke University, was confirmed by the Senate on February 24, 2016, to be the next FDA commissioner, following President Barack Obama’s nomination in September 2015. 

A Pro-Pharma Opinion Piece

  A few weeks ago, an opinion piece was featured on the international public broadcaster Deutsche Welle’s website. In her article, the author shared the “unfair” standards by which pharmaceutical companies are frequently judged. 

AstraZeneca Continues To Prove That It’s No Digital Dinosaur

  A little over a year ago, I wrote about AstraZeneca’s road to becoming a digital transformation leader. With CIO David Smoley at the helm, the pharmaceutical giant is known to have been an early adopter of many cloud solutions, including Box, Salesforce, and Microsoft Office 365. While Smoley’s cloud-first mentality has helped save a […]